HPV programme extended
The Department of Health has announced (PDF) that the human papillomavirus vaccination programme is to be extended to include young women aged 17-18.
The decision to use Cervarix® has been criticised but this announcement does start to explain why the programme is using an apparently inferior vaccine.
Action: Clinicians should be aware of the extension to the vaccination programme.
« EMEA restrict two quinolone antibiotics | Dementia, BP and Statins » |
Leave a Comment